| Title |
Current Trends in the Management of Gastroesophageal Reflux Disease
|
|---|---|
| Published in |
Gut and Liver, April 2017
|
| DOI | 10.5009/gnl16615 |
| Pubmed ID | |
| Authors | |
| Abstract |
Gastroesophageal reflux disease (GERD) defined as heartburn and/or regurgitation is one of the most common gastrointestinal disorder managed by gastroenterologists and primary care physicians. There is an increase in GERD prevalence since 1995 particularly in North America and East Asia. Over the past three decades proton pump inhibitors (PPIs) had become the mainstay medical therapy for management of GERD. However, over the last decade there is an increasing awareness amongst physicians and patient population regarding the side effects of otherwise considered safe PPIs. In addition, a marked decline in the utilization of surgical fundoplication and the rise in the development of nonmedical therapeutic modalities for GERD is being observed. This review focuses on different management strategies for GERD, optimal management of refractory GERD with special focus on available endoluminal therapies and the future directions. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 3 | 43% |
| United States | 1 | 14% |
| Unknown | 3 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 100% |
Mendeley demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 435 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 72 | 17% |
| Student > Master | 34 | 8% |
| Student > Postgraduate | 33 | 8% |
| Other | 21 | 5% |
| Researcher | 18 | 4% |
| Other | 47 | 11% |
| Unknown | 210 | 48% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 141 | 32% |
| Nursing and Health Professions | 24 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 24 | 6% |
| Biochemistry, Genetics and Molecular Biology | 6 | 1% |
| Computer Science | 4 | <1% |
| Other | 18 | 4% |
| Unknown | 218 | 50% |